Daniel E. Owens

Daniel E. Owens (senior executive) discloses dealings in Treace Medical Concepts, Inc. to SEC (Form 4). The record holds 26 filings, for trades running from 27 April 2021 to 15 March 2023.

Market trades split into 1 purchase (€56k) and 12 sales (€541k). Sales outweigh purchases by €485k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 2 share grants and 11 option exercises. So far in 2023, the count stands at no purchases and 2 sales.

The newest entry dates from 17 March 2023: an open-market sale of €133k, in Treace Medical Concepts, Inc. The last purchase on record was published on 29 April 2021, which is 2,020 days ago. The median gap between a trade and its publication by SEC (Form 4) is 1 day. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.